Resolution or improvement of telangiectasias ( · people with telangiectasias and reticular veins
1 finding from 1 review
Adverse events ‐ hyperpigmentation ( · people with telangiectasias and reticular veins
Foam showed no clear difference in adverse events ‐ hyperpigmentation ( compared with sclerotherapy (any sclerosant) (low certainty).
1 finding from 1 review
Adverse events ‐ matting ( · people with telangiectasias and reticular veins
Foam may leads to higher adverse events ‐ matting ( compared with sclerotherapy (any sclerosant) (low certainty).
1 finding from 1 review
Pain ( · people with telangiectasias and reticular veins
1 finding from 1 review
Recurrence · people with telangiectasias and reticular veins
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Time to resolution · people with telangiectasias and reticular veins
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life · people with telangiectasias and reticular veins
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of participants developing a new pressure ulcer · pressure ulcer prevention
1 finding from 1 review
Time to pressure ulcer development · pressure ulcer prevention
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Support surface associated patient comfort · pressure ulcer prevention
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All reported adverse events · pressure ulcer prevention
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Health‐related quality of life · pressure ulcer prevention
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cost‐effectiveness · pressure ulcer prevention
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Incidence of healed pressure ulcers, short‐term · people of any age with an existing pressure ulcer of Category/Stage II or above
It is very uncertain whether hydropolymer foam dressing changes incidence of healed pressure ulcers, short‐term compared with silicone foam dressing (very low certainty).
1 finding from 1 review
Time to complete healing · people of any age with an existing pressure ulcer of Category/Stage II or above
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events, short‐term · people of any age with an existing pressure ulcer of Category/Stage II or above
It is very uncertain whether hydropolymer foam dressing changes adverse events, short‐term compared with silicone foam dressing (very low certainty).
1 finding from 1 review
Quality of life · people of any age with an existing pressure ulcer of Category/Stage II or above
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Ulcer healing · people with venous leg ulcers
polyurethane foam dressing showed no clear difference in time to healing compared with hydrocellular foam dressing (low certainty).
4 findings from 1 review
Show 1 more finding
Change in ulcer size · people with venous leg ulcers
1 finding from 1 review
Proportion of participants experiencing adverse events · people with venous leg ulcers
polyurethane foam dressing showed no clear difference in proportion of participants experiencing adverse events compared with hydrocellular foam dressing (low certainty).
1 finding from 1 review